Gland Pharma Limited (GLAND.NS) NSE

1,726.30

-8.6(-0.50%)

Updated at December 05 09:35AM

Currency In INR

Valuation

Market Cap255.94B
Enterprise Value233.52B
P/E Ratio36.16
PEG Ratio13.86
Price/Sales Ratio4.93
Price/Book Ratio2.99
Enterprise/Revenue4.51
Enterprise/EBITDA18.41

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.23

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue56.17B
Revenue/Share352.12
Gross Profit31.54B
EBITDA12.31B
Net Income6.99B
Diluted EPS42.4

Balance Sheet

Total Cash27.04B
Total Cash/Share164.12
Total Debt3.02B
Total Debt/Equity0.03
Current Ratio4.13
Book Value Per Share580.41

Price History

52-Week Change-3.66
52-Week High2,131
52-Week Low1,277.8
Moving Average 50 Days1,886.91
Moving Average 200 Days1,757.34

Statistics

Average Volume185,353
Shares Outstanding164.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate18
Trailing Annual Dividend Yield1.04
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A